Journal of Big Data Research

Professor Qifeng Bai, Professor, School Of Basic Medical Sciences

ORCID: 0000-0001-7296-6187
Editorial Board

Professor Qifeng Bai PhD

Professor, School Of Basic Medical Sciences ORCID: 0000-0001-7296-6187 · China

Editorial leadership for Journal of Big Data Research ISSN 2768-0207

Research interests

  • Artificial Intelligence (Ai) For Drug Design
  • Discovery Deep Learning
  • Geometric Deep Learning Molecular Dynamics Simulations Computational Biology
  • Cheminformatics
  • And Biomedical Informatics Software Development For Drug Design

Biography

Professor Qifeng Bai is a distinguished computational scientist specializing in Artificial Intelligence (AI) for Drug Design and Computational Biology. His research centers on integrating deep learning, machine learning, and molecular dynamics simulation to accelerate new drug discovery. He is the lead developer of the MolAICal software tool, which utilizes AI and classical algorithms for 3D drug design. Dr. Bai's expertise in Biomedical Informatics and Cheminformatics focuses on studying the biological mechanisms of proteins and ligands to promote efficient pharmaceutical research.


Professional Background:
  • Professor (Current, Since 2022) - School Of Basic Medical Sciences, Lanzhou University.
     
Achievements:
  • Lead Developer of MolAICal software for 3D drug design.
  • Associate Editor for Frontiers In Chemistry (Medicinal And Pharmaceutical Chemistry).
     
Current Research Projects:
  • MolAICal Software Development: Continuously developing and improving the software for 3D structure-based drug design using deep learning.
  • Antibody And Nanobody Design: Utilizing adaptive autoregressive diffusion approaches for designing active humanized antibodies.
     
Academic Profiles of Professor Qifeng Bai

Explore his academic and professional presence across trusted platforms:

Considering JBR for your work?

This journal is guided by Professor Qifeng Bai (Professor, School Of Basic Medical Sciences ORCID: 0000-0001-7296-6187) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.

Start your submission

Menu